337828 <common-name>2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(trifluoromethyl)phenyl]methylideneamino]acetamide</common-name> <description>2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(trifluoromethyl)phenyl]methylideneamino]acetamide is a chemical compound with the formula C24H17BrF3N5OS. With an average molecular weight of 560.40 g/mol, 2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(trifluoromethyl)phenyl]methylideneamino]acetamide is a heavy molecule.</description> <cas>303103-49-3</cas> <pubchem-id>6868967</pubchem-id> <chemical-formula>C24H17BrF3N5OS</chemical-formula> <weight>560.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T20:47:59Z</created-at> <updated-at type="dateTime">2026-08-30T20:47:59Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NN=CC3=CC=CC=C3C(F)(F)F)C4=CC=C(C=C4)Br</moldb-smiles> <moldb-formula>C24H17BrF3N5OS</moldb-formula> <moldb-inchi>InChI=1S/C24H17BrF3N5OS/c25-18-12-10-16(11-13-18)22-31-32-23(33(22)19-7-2-1-3-8-19)35-15-21(34)30-29-14-17-6-4-5-9-20(17)24(26,27)28/h1-14H,15H2,(H,30,34)/b29-14+</moldb-inchi> <moldb-inchikey>XUORTDMAWLCAQR-IPPBACCNSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">559.02893</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM333721</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[5-(4-bromophenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(trifluoromethyl)phenyl]methylideneamino]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288257</sync-id> <structure-inchikey>XUORTDMAWLCAQR-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800000002800000000000000000000400000000000000200000000000802000004008000002084000000100000400000000000200000000000000000000000000000000000000020000000000200000004800010000000000000014000000000000080000000800410080100000040000000000000000000004000000000800000000000000084880000010100000000000000000000000000000000000000000000080000040000000000440000000000002c00000000000000004000000000000100004000000000000000002000000200000000000000000040000000001048000000000400800000010000000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEHQCgAAAAD AwZAKAAAAAMEB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMEEAAgAAAAAgYAYAAA AAICBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQcAKAAAAAMDBgBoAAAAAwMB BkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEG QCgAAAADBAYAIAAAAAQJACAAAAABCQAgAAAAAQkAIAAAAAEGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBIwAg AAAAAQsAAWgMAQJoDAIDaAwDBGgMBAVoDAMGIAYHaAwHCGgMCAloDAkKaAwK CwALDAAMDQANDigCDQ8gDxAgEBEoAhESIBITaAwTFGgMFBVoDBUWaAwWF2gM FxgAGBkAGBoAGBsABxwgHB1oDB0eaAweH2gMHyBoDCAhaAwfIgAFAGgMCgZo DBcSaAwhHGgMQgQAAAAGAAUEAwIBBQgHBgoJBhMUFRYXEgYdHh8gIRwXBAAA AAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:38:47Z</structure-indexed-at> </compound>